Author
Listed:
- Diego Scheggia
(Istituto Italiano di Tecnologia
University Hospital Center Lausanne, CH-)
- Rosa Mastrogiacomo
(Istituto Italiano di Tecnologia)
- Maddalena Mereu
(Istituto Italiano di Tecnologia
Universita’ degli Studi di Padova)
- Sara Sannino
(Istituto Italiano di Tecnologia)
- Richard E. Straub
(Johns Hopkins University Medical Campus)
- Marco Armando
(Bambino Gesù Children’s Hospital)
- Francesca Managò
(Istituto Italiano di Tecnologia)
- Simone Guadagna
(Istituto Italiano di Tecnologia)
- Fabrizio Piras
(Neuropsychiatry Laboratory)
- Fengyu Zhang
(Johns Hopkins University Medical Campus)
- Joel E. Kleinman
(Johns Hopkins University Medical Campus)
- Thomas M. Hyde
(Johns Hopkins University Medical Campus)
- Sanne S. Kaalund
(Bispebjerg University Hospital)
- Maria Pontillo
(Bambino Gesù Children’s Hospital)
- Genny Orso
(IRCCS E. Medea Scientific Institute)
- Carlo Caltagirone
(Neuropsychiatry Laboratory)
- Emiliana Borrelli
(University of California)
- Maria A. Luca
(Università di Cagliari)
- Stefano Vicari
(Bambino Gesù Children’s Hospital)
- Daniel R. Weinberger
(Johns Hopkins University Medical Campus
Johns Hopkins School of Medicine)
- Gianfranco Spalletta
(Neuropsychiatry Laboratory
Baylor College of Medicine)
- Francesco Papaleo
(Istituto Italiano di Tecnologia)
Abstract
In the original version of this Article, references in the Methods section incorrectly referred to references in the Supplementary References section. The relevant references (now numbered 20, 27, 42, 47, 69–80) have been removed from the Supplementary References section of the Supplementary Information file and added to the References section of the main manuscript, in both the PDF and HTML versions of the Article.
Suggested Citation
Diego Scheggia & Rosa Mastrogiacomo & Maddalena Mereu & Sara Sannino & Richard E. Straub & Marco Armando & Francesca Managò & Simone Guadagna & Fabrizio Piras & Fengyu Zhang & Joel E. Kleinman & Thoma, 2018.
"Publisher Correction: Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment,"
Nature Communications, Nature, vol. 9(1), pages 1-1, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06062-y
DOI: 10.1038/s41467-018-06062-y
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06062-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.